Compare TWST & WLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | WLYB |
|---|---|---|
| Founded | 2013 | 1807 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Books |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2018 | N/A |
| Metric | TWST | WLYB |
|---|---|---|
| Price | $46.04 | $31.55 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $47.89 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 1.8K |
| Earning Date | 02-02-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 4.43% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.87 |
| Revenue | $391,557,000.00 | ★ $1,665,756,000.00 |
| Revenue This Year | $16.77 | $0.02 |
| Revenue Next Year | $15.06 | $2.32 |
| P/E Ratio | ★ N/A | $16.27 |
| Revenue Growth | ★ 18.59 | N/A |
| 52 Week Low | $23.30 | $30.10 |
| 52 Week High | $54.74 | $46.81 |
| Indicator | TWST | WLYB |
|---|---|---|
| Relative Strength Index (RSI) | 69.16 | 42.70 |
| Support Level | $39.66 | $31.97 |
| Resistance Level | $43.34 | $32.65 |
| Average True Range (ATR) | 2.50 | 0.34 |
| MACD | 0.16 | 0.15 |
| Stochastic Oscillator | 77.41 | 33.01 |
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.